These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, Khalighi K, Machado C, Rubenstein DS, Volosin KJ, PainFREE Rx II Investigators. Circulation; 2004 Oct 26; 110(17):2591-6. PubMed ID: 15492306 [Abstract] [Full Text] [Related]
5. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators. Bardy GH, Yee R, Jung W. J Am Coll Cardiol; 1996 Aug 26; 28(2):400-10. PubMed ID: 8800117 [Abstract] [Full Text] [Related]
6. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial. Gulizia MM, Piraino L, Scherillo M, Puntrello C, Vasco C, Scianaro MC, Mascia F, Pensabene O, Giglia S, Chiarandà G, Vaccaro I, Mangiameli S, Corrao D, Santi E, Grammatico A, PITAGORA ICD Study Investigators. Circ Arrhythm Electrophysiol; 2009 Apr 26; 2(2):146-53. PubMed ID: 19808459 [Abstract] [Full Text] [Related]
15. [Ventricular tachycardia and ventricular fibrillation. Diagnostic procedure for selection of patients for non-medicamentous therapeutic procedures]. Schmidinger H. Wien Med Wochenschr; 1992 Jun 26; 142(15-16):341-6. PubMed ID: 1481538 [Abstract] [Full Text] [Related]
16. Electrical storm of monomorphic ventricular tachycardia after a cardiac-resynchronization-therapy-defibrillator upgrade. Kantharia BK, Patel JA, Nagra BS, Ledley GS. Europace; 2006 Aug 26; 8(8):625-8. PubMed ID: 16772367 [Abstract] [Full Text] [Related]
17. Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock. Mishkin JD, Saxonhouse SJ, Woo GW, Burkart TA, Miles WM, Conti JB, Schofield RS, Sears SF, Aranda JM. J Am Coll Cardiol; 2009 Nov 24; 54(22):1993-2000. PubMed ID: 19926003 [Abstract] [Full Text] [Related]
18. Clinical experience with antitachycardia pacing and improved detection algorithms in a new implantable cardioverter-defibrillator. Wietholt D, Block M, Isbruch F, Böcker D, Borggrefe M, Shenasa M, Breithardt G. J Am Coll Cardiol; 1993 Mar 15; 21(4):885-94. PubMed ID: 8185728 [Abstract] [Full Text] [Related]
19. The implantable cardioverter defibrillator: technology, indications, and impact on cardiovascular survival. Bhatia A, Cooley R, Berger M, Blanck Z, Dhala A, Sra J, Axtell-Mcbride K, Vandervort C, Akhtar M. Curr Probl Cardiol; 2004 Jun 15; 29(6):303-56. PubMed ID: 15159713 [Abstract] [Full Text] [Related]